83% of seed-stage founders sign term sheets without reading the IP clauses. Hayat Amin calls this the most expensive signature in startup history — not because of the valuation cap, but because of the four provisions buried in the boilerplate that determine who actually owns your patents, data assets, and trade secrets after the ink dries.
Companies with patents are 10.2x more likely to secure early-stage funding. But that stat means nothing if the IP clauses in your term sheet hand the asset that drives the funding to a board you no longer control.
What IP Clauses Are Hiding in a Standard Term Sheet?
Every standard term sheet contains four IP-related provisions that most founders treat as boilerplate: the IP assignment clause, the pre-existing IP schedule, the background IP definition, and the change-of-control IP transfer trigger. Each one determines whether your competitive position survives the fundraise or gets silently transferred to your investors. Beyond Elevation reviews hundreds of term sheets each year, and the pattern is always the same — founders fight over valuation while signing away the asset that creates it.
The IP assignment clause requires founders and employees to assign all inventions to the company. Standard. Expected. But the scope language is where the damage hides. A well-drafted clause assigns company-related inventions only. A poorly drafted one assigns everything — including side projects, pre-existing patents, and technology you developed before the company existed.
The pre-existing IP schedule is the carve-out that protects what you brought to the table. If you built core technology before incorporating, you need a formal schedule listing every piece of pre-existing IP you retain. Miss one item and it gets swept into the general assignment by default.
The background IP definition separates inventions developed using company resources from inventions developed independently. In AI companies, this line is nearly impossible to draw cleanly — your model architecture intuition, data optimization techniques, and workflow automation patterns all blur between personal know-how and company IP.
The change-of-control IP transfer is the clause founders discover too late. It specifies what happens to IP rights when board composition shifts — in a down round, a new lead investor, or a founder departure. If the clause is investor-friendly, a board change triggers an automatic IP license or transfer to a new controlling entity.
Why Do the IP Clauses in a Term Sheet Matter More Than Valuation?
IP clauses in a term sheet determine the long-term ownership and control of the asset that drives 70–90% of enterprise value. A $10M pre-money valuation means nothing if the IP assignment language gives your board the unilateral right to license your patents to a competitor after a governance change. Hayat Amin argues that founders who negotiate valuation caps while ignoring IP provisions are optimizing the wrong variable — valuation is a number on paper, but IP ownership is a structural fact that survives every future round, every board change, and every exit.
The math is direct. An IP portfolio that stays under founder-aligned control generates a 2–4x exit premium. The same portfolio, encumbered by investor-friendly transfer clauses, gets discounted 20–40% because acquirers price the governance risk into their offer.
Hayat Amin proved this in a restructuring where the founders initially signed a term sheet that granted their Series A investors a perpetual, royalty-free license to all company IP upon a change of control. When the company received an acquisition offer 18 months later, the acquirer's due diligence team flagged the clause — and reduced their offer by $4M because the IP came with a perpetual license that could not be revoked.
What Is a Pre-Existing IP Carve-Out and Why Must Every Founder Demand One?
A pre-existing IP carve-out is a formal schedule attached to the term sheet that lists every piece of intellectual property the founder developed before incorporating. Without this schedule, all prior inventions get swept into the company's IP assignment by default — and from there, they fall under investor governance provisions. This is not a theoretical risk. Beyond Elevation sees 3–5 founders per quarter who discover post-closing that their pre-incorporation technology now belongs to the company under terms they did not intend.
Hayat Amin's Pre-Existing IP Inventory Method requires founders to complete three steps before signing any term sheet:
Step 1: Catalogue every invention. List every piece of technology, every algorithm, every dataset, every prototype you built before the company was incorporated. Include unfinished projects and abandoned prototypes — if you ever want to use them again, they need to be on this list.
Step 2: Document the development timeline. For each item, record when it was created, what resources were used, and whether any company resources contributed to its development. This timeline is your evidence if ownership is ever disputed.
Step 3: Define the license-back terms. For pre-existing IP that the company uses, negotiate a formal license from you to the company — with terms that survive a change of control. This ensures the company has the rights it needs while you retain ownership of the underlying asset.
How Should Change-of-Control IP Clauses Work in a Founder-Friendly Term Sheet?
A founder-friendly change-of-control IP provision limits what happens to intellectual property when board composition shifts, a new lead investor takes control, or the founder departs. The default investor-friendly version gives the new controlling party broad rights to license, sublicense, or transfer IP without founder consent. The founder-friendly version requires a supermajority vote for any IP licensing, transfer, or encumbrance decision — ensuring no single investor class can unilaterally monetize or dispose of the company's core asset.
Founders should insist on four protections:
1. Supermajority IP consent. Any decision to license, sell, or encumber core IP requires approval from at least one founder-designated board member — not just a majority of investor-appointed directors.
2. No drag-along on IP. Drag-along rights should explicitly exclude intellectual property. A drag-along that forces a minority shareholder to sell equity should not automatically include IP licenses or assignments that were not part of the original deal.
3. Founder license-back on departure. If a founder leaves, they retain a limited, non-exclusive license to use technology they personally invented for non-competitive purposes. This prevents the scenario where a departing founder cannot reference their own prior work.
4. Anti-warehousing clause. If the company stops actively developing or commercializing a patented technology for 24 months, the inventor has the option to request reassignment. This prevents investors from shelving valuable IP after a pivot.
What IP Audit Should You Complete Before Signing Any Term Sheet?
The pre-term-sheet IP audit is the single highest-ROI activity a founder completes before a fundraise. It takes 2–3 weeks, costs a fraction of what the wrong IP clauses will cost over the life of the company, and gives the founder the leverage to negotiate from knowledge rather than hope. The pre-term-sheet IP audit covers five areas:
1. Ownership verification. Confirm that every piece of company IP is properly assigned through executed agreements with founders, employees, and contractors. Any gaps become negotiation liabilities.
2. Pre-existing IP inventory. Complete the three-step process above and attach the schedule to the term sheet as an exhibit.
3. Freedom-to-operate analysis. Verify that the company's products do not infringe third-party patents. Investors increasingly demand FTO analysis, and providing it proactively signals sophistication.
4. IP valuation baseline. Establish an independent valuation of the IP portfolio using income and market approaches. This number anchors the valuation negotiation and prevents the IP from being undervalued in the cap table.
5. Clause review by an IP strategist. Have an IP strategist — not just a corporate lawyer — review every IP-related clause. Corporate lawyers optimize for deal closure. IP strategists optimize for long-term asset protection.
Hayat Amin reminds founders that the IP audit is not a cost — it is the price of keeping the asset that makes the company worth acquiring. The difference between a founder who completes this audit and one who does not is the difference between a $20M exit and a $12M exit on the same company with the same revenue.
FAQ
What happens to my IP if my startup takes venture capital?
When a startup takes venture capital, all IP gets assigned to the company through standard IP assignment agreements. The critical question is not whether the IP is assigned — it is who controls what happens to it afterward. The IP clauses in your term sheet determine whether the founders or the investor-controlled board have the final say on licensing, transferring, or encumbering the company's intellectual property assets.
Can investors take my patents in a down round?
Investors cannot directly seize patents in a down round, but they gain board control — and if the change-of-control IP provisions are investor-friendly, that board control gives them effective authority over all IP decisions. This is why negotiating founder-protective IP clauses in your term sheet before the first round matters more than negotiating anti-dilution ratchets.
Should I patent before or after raising a round?
File provisional patent applications before raising. A filed patent establishes a priority date, demonstrates defensibility to investors, and ensures the invention is documented before the IP assignment clause takes effect. The cost is $1,500–3,000 per provisional. Hayat Amin's rule: file before the term sheet, because investors price defensibility, not vision.
Do I need an IP lawyer or an IP strategist to review my term sheet?
You need both. A corporate lawyer ensures the legal language is enforceable. An IP strategist — like the team at Beyond Elevation — ensures the clauses protect the value of your intellectual property over the life of the company. Most corporate lawyers approve clauses that are legally sound but commercially catastrophic because they do not understand IP valuation or licensing dynamics.